Nu Holdings' Regional Chief Faces Valuation Hurdle as Mexico Expansion Accelerates
Markets Daniel Marsh

Nu Holdings' Regional Chief Faces Valuation Hurdle as Mexico Expansion Accelerates

Nu Holdings (NU) appoints Livia Chanes as regional head, facing valuation pressure with a P/E of 21.3, as it seeks growth beyond Brazil in Mexico and Colombia.

NU INTR PAGS STNE
NJ Transit Secures $302M State Boost as Fare Revenue Stays Flat
Economy Daniel Marsh

NJ Transit Secures $302M State Boost as Fare Revenue Stays Flat

NJ Transit approved a $3.5B operating budget with state direct aid rising 31% to $302M, while fare revenue holds at $980M, underscoring fiscal challenges.

NYC
American Airlines Faces Valuation Pressure Ahead of Q2 Earnings Report
Earnings James Calloway

American Airlines Faces Valuation Pressure Ahead of Q2 Earnings Report

American Airlines stock trades at a steep valuation multiple compared to peers as it prepares to report Q2 earnings on July 23, with profit conversion and fuel costs in focus.

AAL UAL DAL USO
ASX 200 Closes Lower as Materials Slide Offsets Broad Gains
Markets Daniel Marsh

ASX 200 Closes Lower as Materials Slide Offsets Broad Gains

The S&P/ASX 200 fell 0.50% to 8,796.7 on Friday, dragged by a 2.91% decline in materials, while seven other sectors gained. BHP, Rio Tinto, and Fortescue led the losses.

BHP RIO
Nifty 50 Hits New High as Five Stocks Drive Two-Thirds of Gains
Markets Daniel Marsh

Nifty 50 Hits New High as Five Stocks Drive Two-Thirds of Gains

India's Nifty 50 advanced 1.09% to 24,334.25, driven by five major stocks that accounted for 66% of the gain, while midcap and smallcap indices declined.

Vodafone Shares Jump as Niel's Vega Boosts Voting Stake to Near 20%
Markets Daniel Marsh

Vodafone Shares Jump as Niel's Vega Boosts Voting Stake to Near 20%

Vodafone shares climbed 3.2% after Xavier Niel's Vega raised its voting stake to 19.87%, just below the 20% threshold. Vega reiterated it has no plans to make an offer, viewing the holding as a long-term strategic investment.

VOD
GSK Plummets After Failed Cough Drug Trial Wipes Out £2.36B
Markets Daniel Marsh

GSK Plummets After Failed Cough Drug Trial Wipes Out £2.36B

GSK shares fell 3% after a phase III trial failure for its chronic cough drug camlipixant erased £2.36 billion in market value, more than the cost of acquiring BELLUS.

GSK
FTSE 100 Shields Against Tech Rout; Burberry Dips on Travel Caution
Markets Daniel Marsh

FTSE 100 Shields Against Tech Rout; Burberry Dips on Travel Caution

The FTSE 100 opened down 0.25% but outperformed as its low tech weighting cushioned the impact of a global chip selloff. Burberry fell 5.2% despite 5% sales growth, with CFO citing tourism effects.

EWU
Lloyds Shares Decline as Higher Buyback Price Raises Strategic Concerns
Markets Daniel Marsh

Lloyds Shares Decline as Higher Buyback Price Raises Strategic Concerns

Lloyds shares dipped 2.2% as the average buyback price rose 14.9% from Q1, reducing the impact of share repurchases and raising strategic questions.

EGYM-Playlist $7.5B Merger Targets Healthcare and Corporate Fitness Spend
Markets Daniel Marsh

EGYM-Playlist $7.5B Merger Targets Healthcare and Corporate Fitness Spend

EGYM's $7.5 billion merger with Playlist aims to tap into healthcare and corporate budgets, leveraging data and connected fitness to unlock new revenue streams beyond memberships.

LTH PLNT
Eurowag Shares Slide 7.4% After TA Associates Halves Stake
Markets Daniel Marsh

Eurowag Shares Slide 7.4% After TA Associates Halves Stake

Eurowag shares fell 7.4% to 100p after TA Associates sold 30 million shares, reducing its stake to 12.7% and halving its original block since September.

EWG
Alphabet Loses $200B on Gemini 3.5 Pro Delay, AI Strategy Questioned
Technology Sarah Chen

Alphabet Loses $200B on Gemini 3.5 Pro Delay, AI Strategy Questioned

Alphabet shares fell 4.44% on Thursday, erasing nearly $200 billion in market value, as reports of a delay in the Gemini 3.5 Pro launch raised doubts about the company's AI investment strategy.

GOOGL META NVDA MSFT